Eskelund, C. W., Albertsson-Lindblad, A., Kolstad, A., Laurell, A., Räty, R., Pedersen, L. B., Geisler, C. H., Jerkeman, M. and Grønbæk, K. (2018) “Lenalidomide plus bendamustine-rituximab does not overcome the adverse impact of TP53 mutations in mantle cell lymphoma”, Haematologica. Pavia, Italy, 103(11), pp. e541-e543. doi: 10.3324/haematol.2018.194399.